✦ LIBER ✦

Imatinib does not impair specific antitumor T-cell immunity in patients with chronic myeloid leukemia

✍ Scribed by Bocchia, M; Abruzzese, E; Forconi, F; Ippoliti, M; Trawinska, M M; Pirrotta, M T; Raspadori, D; Tozzi, M; Gozzetti, A; Lauria, F

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Durability of molecular remission in chr

✍ Lange, T; Bumm, T; Mueller, M; Otto, S; Al-Ali, H-K; Grommisch, L; Musiol, S; Fr 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

Recovery of Functional T Cells Specific

✍ M. Hoegh-Petersen; Y. Liu; S. Liu; A. Ugarte-Torres; K. Fonseca; F. Khan; J. Sto 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Imatinib mesylate (STI-571) given concur

✍ Koh, L P; Hwang, W Y K; Chuah, C T H; Linn, Y C; Goh, Y T; Tan, C H; Ng, H J; Ta 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 128 KB

High-dose busulfan, cyclophosphamide, an

✍ Farag, S S; Bolwell, B J; Elder, P J; Kalaycio, M; Lin, T; Pohlman, B; Penza, S; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 191 KB